You are here

  • Home
  • Archive
  • Volume 88, Issue 5
  • Evaluation of no evidence of progression or active disease (nepad) in patients with primary progressive multiple sclerosis in the oratorio trial

Article metrics

Article menu
Download PDFPDF
Poster Abstracts
Abstracts
83
Evaluation of no evidence of progression or active disease (nepad) in patients with primary progressive multiple sclerosis in the oratorio trial

 

Online download statistics by month:

Online download statistics by month: May 2017 to June 2022

AbstractFullPdf
May 201796011
Jun 201766013
Jul 20174203
Aug 20179202
Sep 201712409
Oct 201716408
Nov 20178602
Dec 20179605
Jan 201813802
Feb 201814608
Mar 20184402
Apr 20187603
May 201810603
Jun 201834403
Jul 201815409
Aug 201810404
Sep 201815209
Oct 201810802
Nov 20189202
Dec 20187001
Jan 20193202
Feb 20195002
Mar 20193000
Apr 20198805
May 20195201
Jun 20197203
Jul 20195800
Aug 20194800
Sep 20194402
Oct 20195402
Nov 20195000
Dec 20194800
Jan 20203200
Feb 20201402
Mar 20201600
Apr 2020800
May 20202200
Jun 20202808
Jul 20202002
Aug 20201600
Sep 20203200
Oct 20203200
Nov 20204800
Dec 20203600
Jan 20216600
Feb 20212800
Mar 20213400
Apr 20211600
May 20211000
Oct 2021800
Nov 2021600
Dec 20212200
Jan 20222100
Feb 20221800
Mar 20221200
Apr 20221400
May 20227400
Jun 20222800
Total35870130